Search the GHTC website

Global health R&D delivers for Wisconsin

US government investment in global health R&D has delivered

$62.0 million
to Wisconsin research institutions
800+ new jobs
for Wisconsin
Global health R&D at work in Wisconsin

Aiming to stop the devastation of Zika, researchers at the University of Wisconsin (UW) at Madison are testing if mosquitoes—artificially infected with a bacterium called Wolbachia, found in 40 percent of the world’s insects—could be released into the wild to control Zika. Scientists from UW-Madison have already released Wolbachia-infected mosquitoes into countries with dengue virus, a related infection, to study the effect. In the lab, mosquitoes with Wolbachia have proven less capable of harboring Zika, indicating the bacterium could be used as a biological control mechanism. Another UW-Madison study found that monkeys infected with Zika are protected from future infection. These findings suggest that a vaccine against Zika should be effective.

  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: PATH/Gabe Bienczycki